Common Statin Intolerance Variants in ABCB1 and LILRB5 Show Synergistic Effects on Statin Response: An Observational Study Using Electronic Health Records
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Common Statin Intolerance Variants in ABCB1 and LILRB5 Show Synergistic Effects on Statin Response: An Observational Study Using Electronic Health Records
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-01
DOI
10.3389/fgene.2021.713181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
- (2021) Emily Herrett et al. BMJ-British Medical Journal
- Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
- (2021) Camilla Ditlev Lindhardt Johannesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Predictors of Statin Intolerance in Patients with a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Healthcare Institution
- (2020) Tami L. Bair et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The mutational constraint spectrum quantified from variation in 141,456 humans
- (2020) Konrad J. Karczewski et al. NATURE
- Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker–Induced Angioedema
- (2020) Cyrielle Maroteau et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of Statin-Induced Myotoxicity
- (2020) Ping Siu Kee et al. Frontiers in Genetics
- Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
- (2019) Connie B. Newman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Statin Toxicity
- (2019) Natalie C. Ward et al. CIRCULATION RESEARCH
- Muscle and statins: from toxicity to the nocebo effect
- (2019) Juan Pedro-Botet et al. Expert Opinion On Drug Safety
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Treatment patterns of lipid‐lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
- (2019) Wen‐Jone Chen et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
- (2019) Richard Myles Turner et al. Journal of Clinical Medicine
- Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence
- (2018) Liam R Brunham et al. CARDIOVASCULAR RESEARCH
- Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations
- (2018) Albert Selva-O’Callaghan et al. Expert Review of Clinical Immunology
- Statin-Associated Muscle Disease: Advances in Diagnosis and Management
- (2018) Beth A. Taylor et al. Neurotherapeutics
- A common missense variant of LILRB5 is associated with statin intolerance and myalgia
- (2017) Moneeza K Siddiqui et al. EUROPEAN HEART JOURNAL
- Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS)
- (2017) Harry L Hébert et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Cohort profile: the Scottish Research register SHARE. A register of people interested in research participation linked to NHS data sets
- (2017) Brian McKinstry et al. BMJ Open
- Genetic determinants of lipid-lowering response to atorvastatin therapy in an Indian population
- (2016) P. Kadam et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Common and rare variants associating with serum levels of creatine kinase and lactate dehydrogenase
- (2016) Ragnar P. Kristjansson et al. Nature Communications
- Association between SLCO1B1 521 T>C and 388 A>G Polymorphisms and Statins Effectiveness: A Meta-Analysis
- (2015) Rong Dai et al. Journal of Atherosclerosis and Thrombosis
- ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysis
- (2015) Jia Su et al. Lipids in Health and Disease
- CKM and LILRB5 Are Associated With Serum Levels of Creatine Kinase
- (2014) M.-P. Dube et al. Circulation-Cardiovascular Genetics
- Phenotype Standardization for Statin-Induced Myotoxicity
- (2014) A Alfirevic et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review
- (2014) William J. Canestaro et al. GENETICS IN MEDICINE
- SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians
- (2012) Vinicius A. Sortica et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The C3435T polymorphism in ABCB1 influences atorvastatin efficacy and muscle symptoms in a high-risk vascular cohort
- (2011) Michel R. Hoenig et al. Journal of Clinical Lipidology
- Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
- (2011) L R Brunham et al. PHARMACOGENOMICS JOURNAL
- Genetic involvement in statins induced myopathy. Preliminary data from an observational case–control study
- (2010) Luca Puccetti et al. ATHEROSCLEROSIS
- Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
- (2010) L A Donnelly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Influence of genetic variation inCYP3A4andABCB1on dose decrease or switching during simvastatin and atorvastatin therapy
- (2009) Matthijs L. Becker et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Common genetic variation in theABCB1gene is associated with the cholesterol-lowering effect of simvastatin in males
- (2009) Matthijs L Becker et al. PHARMACOGENOMICS
- STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement
- (2009) Julian Little et al. PLOS MEDICINE
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now